Advanced Flower Capital Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AFCG research report →
Range $8.25 – $8.25
Price Chart
About the company
Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry. It primarily originates loans structured as senior loans secured by real estate, equipment, cash flows, and licenses and/or other assets of the loan parties to the extent permitted by applicable laws and the regulations governing such loan parties.
- CEO
- Daniel Neville
- IPO
- 2021
- Employees
- 26
- HQ
- West Palm Beach, FL, US
Get TickerSpark's AI analysis on AFCG
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $73.04M
- P/E
- 3.13
- Fwd P/E
- 4.77
- PEG
- 0.00
- P/S
- 2.17
- P/B
- 0.38
- EV/EBITDA
- 5.34
- Div Yield
- 4.60%
- Gross Margin
- 82.82%
- Op Margin
- 97.67%
- Net Margin
- 71.50%
- ROE
- 13.02%
- ROIC
- 7.88%
Latest fiscal year · YoY change
- Revenue
- $31.32M-39.6%
- Gross Profit
- $28.39M-31.6%
- Op Income
- $-13,653,520
- Net Income
- $-20,673,426-223.2%
- EPS
- $-0.95-221.8%
- OCF Growth
- -47.9%
- FCF Growth
- -47.9%
- 52W High
- $3.84
- 52W Low
- $2.06
- 50D MA
- $3.27
- 200D MA
- $3.02
- Beta
- 1.04
- RSI (14)
- 50
- Avg Volume
- 72.56K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
AFC reported another quarter of rising NAV and stable earnings, while emphasizing disciplined lower-middle-market lending, active balance sheet management, and ongoing recovery work on legacy problem assets.· November 5, 2026
- Net investment income was $0.16 per share, while NAV per share rose to $8.55, up $1.09 or about 15% since the start of the year.
- The portfolio was about $290 million across 18 first-lien senior secured investments, with a 13.3% weighted average yield on income-producing assets.
- Management repurchased about $1 million of stock at $3.46 per share, roughly a 58% discount to NAV, and said the buybacks added about $0.06 per share to NAV this quarter.
- AFC also bought back $19 million of senior notes after quarter-end, reducing near-term debt obligations and booking a gain in Q4.
- Management said the pipeline is active at about $1.1 billion, but new deal deployment is likely to be lumpy and selective.
For Q3 2026, AFC reported total investment income of $8.6 million, net investment income of $3.5 million, or $0.16 per weighted average share, and total expenses of $5 million. Net expenses were $4.8 million versus $5 million in Q2, and NAV per share increased by $0.30 sequentially to $8.55. The company ended the quarter with $361.1 million of principal outstanding, $395.1 million of total assets, and $191.6 million of total net assets. Portfolio yield on income-producing investments was 13.3%, and all investments were senior secured first lien debt. Management said it repurchased approximately 286,000 shares for about $1 million at a weighted average price of $3.46 per share, and that approximately $1.2 million remained under the $5 million authorization. Subsequent to quarter-end, AFC repurchased $19 million of 2027 senior unsecured notes at 96.5% of par, plus accrued interest, leaving about $58 million outstanding. Forward-looking commentary was focused on selective growth rather than formal earnings guidance: management said the pipeline is about $1.1 billion, one $43 million senior secured healthcare services deal is expected to close in the near term, and deal cadence should be choppy/lumpy over the next few quarters. The board is expected to declare the fourth-quarter dividend around December 15.
Dan Neville framed the quarter as one of disciplined capital deployment and active portfolio management. He said AFC is prioritizing higher-quality lower-middle-market opportunities with strong lender protections, while maximizing recoveries on legacy nonaccruals and selectively redeploying capital as repayments come in. His tone was cautious but constructive, emphasizing that the company is not chasing volume and expects deployment to be uneven rather than linear.
Brandon Hetzel highlighted the quarter’s financial profile: $8.6 million of total investment income, $3.5 million of net investment income, and $0.16 per share of NII. He said total expenses were $5 million, weighted average interest rate on debt was 6.2%, gross debt-to-equity was 1.03x, net debt-to-equity was 0.49x, and asset coverage was 197%, above the 150% minimum. He also noted the company’s debt mix, the post-quarter repayment of $96.5 million on the revolver and $5 million on the affiliated credit facility, and the $19 million note repurchase that produced about a $600,000 gain on extinguishment of debt.
Analysts focused on two main areas: recoveries from the Justice Grown situation and the pace of new deal funding. Management declined to comment on active litigation or expected sale proceeds, but said the auctions are upcoming and material updates will be shared at the appropriate time; on deal flow, they said deployment should remain lumpy, with a wide funnel but selective execution based on structure and credit quality. On cannabis, management said Story, Theratrue, and Sunburn are current, with Story’s Arizona extension described as performing well and Sunburn having met its forbearance terms after raising additional equity.
The bullish case from this call is that AFC is seeing a better setup in its target market, with management saying larger private credit managers are moving upmarket and leaving attractive lower-middle-market opportunities. NAV continues to rise, portfolio yield remains high at 13.3%, and the company is using buybacks and debt repurchases to enhance per-share value and reduce obligations. Management also pointed to a large pipeline, current performing non-cannabis investments, and ongoing recoveries from legacy assets.
The main risks are that legacy problem loans still require legal and recovery work, especially Justice Grown and Devi, and management would not give specifics on expected outcomes. New investment deployment may remain uneven, suggesting growth could be choppy rather than steady. There is also ongoing sensitivity in the cannabis book, even though management said the named borrowers are current, and the board’s dividend decision remains dependent on broader taxable-income and capital-allocation considerations rather than just reported NII.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 63.7%
- Shares Outstanding
- 22.40M
- Float Shares
- 14.26M
of shares held by institutions
48 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Cdc Financial, Inc. | 1.75M | ▼ 45.23K |
| Vanguard Group Inc | 936.19K | ▲ 20.04K |
| Gsa Capital Partners Llp | 195.99K | ▲ 2.67K |
| Arrowstreet Capital, Limited Partnership | 173.23K | 0 |
| Jane Street Group, LLC | 170.96K | ▼ 247.52K |
| Citadel Advisors LLC | 166.42K | ▲ 52.02K |
| Mirae Asset Global Etfs Holdings Ltd. | 145.77K | ▼ 74.62K |
| D. E. Shaw & Co., Inc. | 141.76K | ▲ 25.29K |
| Acadian Asset Management LLC | 116.78K | ▲ 8.34K |
| Squarepoint Ops LLC | 108.90K | ▼ 82.90K |
| Susquehanna International Group, Llp | 102.12K | ▼ 97.79K |
| Millennium Management LLC | 90.85K | ▲ 47.37K |
Held by 13 ETFs
Biggest fund positions in AFCG by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Nov 17, 26 | TANNENBAUM LEONARD M | buy | 48,013 |
| Nov 18, 26 | TANNENBAUM LEONARD M | buy | 37,491 |
| Nov 11, 26 | TANNENBAUM LEONARD M | buy | 874 |
| Nov 10, 26 | TANNENBAUM LEONARD M | buy | 20,203 |
| Nov 9, 26 | TANNENBAUM LEONARD M | buy | 8,905 |
| Nov 6, 26 | TANNENBAUM LEONARD M | buy | 18,500 |
| Nov 6, 26 | Tannenbaum Robyn | buy | 10,000 |
| Nov 6, 26 | Hetzel Brandon | buy | 1,500 |
| Sep 30, 26 | TANNENBAUM LEONARD M | buy | 44,643 |
| Sep 29, 26 | TANNENBAUM LEONARD M | buy | 40,081 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AFCG coverage
Recent articles, reports, and earnings notes.
No research on AFCG yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AFCG report →AFC Announces Results of Article 9 Public Sale of Justice Grown's Pennsylvania Dispensaries
globenewswire.com · Nov 16
Advanced Flower Capital Inc. (AFCG) Q3 2026 Earnings Call Transcript
seekingalpha.com · Nov 7
AFC Gamma Q3 Earnings Call Highlights
marketbeat.com · Nov 5
AFC Announces Financial Results for the Third Quarter 2026
globenewswire.com · Nov 5
AFC Schedules Earnings Release and Conference Call for the Third Quarter Ended September 30, 2026
globenewswire.com · Oct 20
AFC Gamma (NASDAQ:AFCG) Director Leonard Tannenbaum Buys 40,081 Shares of Stock
defenseworld.net · Oct 1
AFC Gamma (NASDAQ:AFCG) Director Leonard Tannenbaum Acquires 44,643 Shares of Company Stock
defenseworld.net · Oct 1
Advanced Flower Capital director buys 95,397 shares
defenseworld.net · Oct 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.